[HTML][HTML] Drugs for autoimmune inflammatory diseases: from small molecule compounds to anti-TNF biologics

P Li, Y Zheng, X Chen - Frontiers in pharmacology, 2017 - frontiersin.org
Although initially described as an anti-tumor mediator, tumor necrosis factor-alpha (TNF) is
generally considered as the master pro-inflammatory cytokine. It plays a crucial role in the …

[HTML][HTML] Cardiomyocyte death: mechanisms and translational implications

M Chiong, ZV Wang, Z Pedrozo, DJ Cao… - Cell death & …, 2011 - nature.com
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide.
Although treatments have improved, development of novel therapies for patients with CVD …

Muscle oxygen transport and utilization in heart failure: implications for exercise (in) tolerance

DC Poole, DM Hirai, SW Copp… - American Journal of …, 2012 - journals.physiology.org
The defining characteristic of chronic heart failure (CHF) is an exercise intolerance that is
inextricably linked to structural and functional aberrations in the O2 transport pathway. CHF …

[HTML][HTML] Harnessing tumor necrosis factor alpha to achieve effective cancer immunotherapy

MF Mercogliano, S Bruni, F Mauro, PV Elizalde… - Cancers, 2021 - mdpi.com
Simple Summary Inflammation has been acknowledged as one of the causes of increased
cancer risk. Among the pro-inflammatory mediators, tumor necrosis factor alpha (TNFα) has …

An inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17

L Grine, L Dejager, C Libert… - Cytokine & growth factor …, 2015 - Elsevier
Psoriasis is a skin disease where various cytokines play a detrimental role, yet our
understanding of the disease is still limited. TNF is a validated drug target in psoriasis and …

Proinflammatory cytokines in heart failure: double-edged swords

M Hedayat, MJ Mahmoudi, NR Rose, N Rezaei - Heart failure reviews, 2010 - Springer
Increased circulating and intracardiac levels of proinflammatory cytokines have been
associated with chronic heart failure. Following an initial insult, the increased production of …

Clinical pharmacokinetics and use of infliximab

U Klotz, A Teml, M Schwab - Clinical pharmacokinetics, 2007 - Springer
Tumor necrosis factor-α (TNFα) is a key proinflammatory cytokine involved in chronic
inflammatory diseases. Infliximab, a chimeric (human-murine) monoclonal IgG1 anti-TNFα …

PPAR dual agonists: are they opening Pandora's Box?

P Balakumar, M Rose, SS Ganti, P Krishan… - Pharmacological …, 2007 - Elsevier
Cardiovascular disorders are the major cause of mortality in patients of diabetes mellitus.
Peroxisome proliferator activated receptors (PPARs) are ligand-activated transcription …

Post-infectious group A streptococcal autoimmune syndromes and the heart

WJ Martin, AC Steer, PR Smeesters, J Keeble… - Autoimmunity …, 2015 - Elsevier
There is a pressing need to reduce the high global disease burden of rheumatic heart
disease (RHD) and its harbinger, acute rheumatic fever (ARF). ARF is a classical example of …

Transcription factor NF-κB: an update on intervention strategies

A Panday, ME Inda, P Bagam, MK Sahoo… - Archivum immunologiae …, 2016 - Springer
The nuclear factor (NF)-κB family of transcription factors are ubiquitous and pleiotropic
molecules that regulate the expression of more than 150 genes involved in a broad range of …